Salivary anticandidal activity and saliva composition in an HIV-infected cohort (Q43736230)

26 November 2017

title

Salivary anticandidal activity and saliva composition in an HIV-infected cohort (English)

1 reference

26 November 2017

1 reference

Lin AL

1 reference

26 November 2017

Johnson DA

1 reference

26 November 2017

Patterson TF

1 reference

26 November 2017

Wu Y

1 reference

26 November 2017

Lu DL

1 reference

26 November 2017

Shi Q

1 reference

26 November 2017

Yeh CK

1 reference

26 November 2017

publication date

1 October 2001

1 reference

Oral Microbiology and Immunology

26 November 2017

published in

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

270-278

1 reference

Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Adsorption of human salivary proteins to hydroxyapatite: a comparison between whole saliva and glandular salivary secretions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Host factors associated with HIV-related oral candidiasis. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Salivary anti-candidal assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Fungicidal effect of human lactoferrin against Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

Identification of histatins as tannin-binding proteins in human saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

A population-based study of salivary lysozyme concentrations and candidal counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

An enzyme-linked immunosorbent assay for plasma-lactoferrin. Concentrations in 362 healthy, adult blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Studies on histidine-rich polypeptides from human parotid saliva

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

The relationship between salivary histatin levels and oral yeast carriage

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Effect of donor age on the concentrations of histatins in human parotid and submandibular/sublingual saliva

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Lytic action of lysozyme on Candida albicans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

One-step purification of histidine-rich polypeptides form human parotid saliva and determination of anti-candidal activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Development of an enzyme-linked immunosorbent assay for determination of lysozyme in human parotid and submandibular-sublingual salivas

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Longitudinal study of parotid saliva in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Both IgA subclasses are reduced in parotid saliva from patients with AIDS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Quantitation of salivary, urinary and faecal sIgA in children living in different conditions of antigenic exposure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Selective effects of histidine-rich polypeptides on the aggregation and viability of Streptococcus mutans and Streptococcus sanguis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Alteration of humoral responses to Candida in HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

Anticandidal activity of major human salivary histatins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.016005270.X

7 January 2021

10.1034/J.1399-302X.2001.016005270.X

Identifiers

DOI

1 reference

26 November 2017

1 reference